Almaprism Inc. has been registered in the prefecture of Kyoto as a medical device manufacturer pursuant to the Order for Enforcement of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, Article 23. Registration number: 26BZ200147
Research findings presented at the 15th Meeting of the Japan Society for ADHD
Dr. Takahashi Nagahide of Nagoya University Hospital presented our research findings from the Research and Development Project for a Treatment Device for ADHD using Video Games project (funded by AMED) at the 15th Meeting of the Japan Society for ADHD.

Video Game for the Treatment of ADHD receives AMED Grant for the Research and Development of New Medical Devices
Nagoya University, Hamamatsu Medical University, and Almaprism Inc. were selected as recipients for a Research and Development of New Medical Devices grant from the Japan Agency for Medical Research and Development (AMED)
